$3.40
0.11[3.34%]
At close: Apr 26
$3.40
0[0.00%]
After Hours: 4:20PM EDT
Revance Therapeutics: Insider buying and selling updated today.
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
---|---|---|---|---|---|---|---|---|---|---|
Apr 17, 2024 | Erica Jordan | CHIEF COMMERCIAL OFFICER | -2.392K | $3.80 | -$9.10K | SELL | -2.04% | 114.864K | Apr 16 | View |
Mar 19, 2024 | Dustin Sjuts | PRESIDENT | -12.178K | $5.11 | -$62.19K | SELL | -6.78% | 167.55K | Mar 15 - Mar 18 | View |
Mar 19, 2024 | Dwight Moxie | CLO & GC | -11.394K | $5.12 | -$58.31K | SELL | -7.64% | 137.815K | Mar 15 - Mar 18 | View |
Mar 19, 2024 | Tobin Schilke | CFO | -13.183K | $5.12 | -$67.48K | SELL | -6.40% | 192.666K | Mar 15 - Mar 18 | View |
Mar 08, 2024 | Mark Foley | CEO | 30K | $6.98 | $209.40K | BUY | 2.74% | 1.126381M | Mar 06 | View |
Sep 07, 2023 | Dwight Moxie | SVP, GC & SECRETARY | -34.853K | $17.58 | -$612.62K | SELL | -44.16% | 44.066K | Sep 05 - Sep 06 | View |
Aug 04, 2023 | Mark Foley | CEO | -26.279K | $22.57 | -$593.15K | SELL | -2.69% | 951.288K | Aug 03 | View |
Jul 05, 2023 | Tobin Schilke | CFO | -932 | $20.32 | -$30.59K | SELL | -1.15% | 79.896K | Jun 30 - Jul 03 | View |
Jul 05, 2023 | Mark Foley | CEO | -25.279K | $20.27 | -$639.73K | SELL | -2.52% | 977.567K | Jun 30 - Jul 03 | View |
Jun 20, 2023 | OConnor Carey Kolaja | DIRECTOR | 0 | $23.18 | -$25.30K | SELL-OPTIONS | 0.00% | 16.561K | Jun 15 | View |
Jun 13, 2023 | Dustin Sjuts | PRESIDENT | -5K | $30.82 | -$154.10K | SELL | -3.28% | 147.347K | Jun 09 | View |
Jun 13, 2023 | Mark Foley | CEO | -31.279K | $30.72 | -$960.93K | SELL | -3.02% | 1.002846M | Jun 09 | View |
Jun 05, 2023 | Tobin Schilke | CFO | -3.201K | $30.64 | -$98.07K | SELL | -3.81% | 80.828K | Jun 01 - Jun 02 | View |
May 16, 2023 | Dwight Moxie | SVP, GC & SECRETARY | 20.948K | $34.55 | -$739.34K | GRANT | 43.45% | 69.165K | Feb 02 - May 15 | View |
May 16, 2023 | Tobin Schilke | CFO | 20.948K | $34.55 | -$739.34K | GRANT | 33.21% | 84.029K | Feb 02 - May 15 | View |
May 16, 2023 | Mark Foley | CEO | 105.202K | $34.55 | -$2.43M | GRANT | 11.33% | 1.034125M | Feb 02 - May 15 | View |
May 16, 2023 | Dustin Sjuts | PRESIDENT | 31.38K | $34.55 | -$726.00K | GRANT | 25.94% | 152.347K | Feb 02 - May 15 | View |
May 02, 2023 | Tobin Schilke | CFO | -3.201K | $31.70 | -$101.47K | SELL | -4.83% | 63.081K | May 01 | View |
Apr 04, 2023 | Tobin Schilke | CFO | -3.201K | $32.15 | -$102.91K | SELL | -4.61% | 66.282K | Apr 03 | View |
Browse insider trades on all stocks.